SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX]
COR 359.25+2.0%Feb 6 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cage Rattler who wrote (484)8/14/1998 10:43:00 AM
From: John Lacelle  Read Replies (1) of 1255
 
Theodore,

I saw an advertisement for memory enhancement
studies in the Los Angeles Times. Of course,
they will not mention any drug names or anything.
Everything in these studies will be "double-blind"
meaning not even the doctor will know if the
patient is getting placebo or drug. There are
several companies entering the third phase of
testing with memory drugs. I think that even
with some competition in the market place, Ampalex
will be a winner if the study goes well. It seems
to have very low toxicity, few side effects, and
a powerful and long effect.

As for me, I think I'm going to sell my position for
the tax loss, and buy a fat block and wait for the
data to come out.

-John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News